Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Assembly Biosciences (ASMB) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Assembly Biosciences (ASMB) over the last 5 years, with Q3 2025 value amounting to $12.7 million.

  • Assembly Biosciences' Shares Outstanding (Diluted Average) rose 9973.64% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 9973.64%. This contributed to the annual value of $6.0 million for FY2024, which is 3117.92% up from last year.
  • According to the latest figures from Q3 2025, Assembly Biosciences' Shares Outstanding (Diluted Average) is $12.7 million, which was up 9973.64% from $7.7 million recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Shares Outstanding (Diluted Average) peaked at $48.4 million during Q3 2022, and registered a low of $4.0 million during Q4 2022.
  • For the 5-year period, Assembly Biosciences' Shares Outstanding (Diluted Average) averaged around $19.4 million, with its median value being $6.9 million (2024).
  • In the last 5 years, Assembly Biosciences' Shares Outstanding (Diluted Average) plummeted by 9116.65% in 2023 and then soared by 9973.64% in 2025.
  • Quarter analysis of 5 years shows Assembly Biosciences' Shares Outstanding (Diluted Average) stood at $43.3 million in 2021, then tumbled by 90.68% to $4.0 million in 2022, then rose by 13.47% to $4.6 million in 2023, then soared by 31.18% to $6.0 million in 2024, then surged by 111.27% to $12.7 million in 2025.
  • Its last three reported values are $12.7 million in Q3 2025, $7.7 million for Q2 2025, and $7.5 million during Q1 2025.